Global Restriction Endonucleases Market Research Report 2022

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.
Due to the COVID-19 pandemic, the global Restriction Endonucleases market size is estimated to be worth US$ 269.6 million in 2021 and is forecast to a readjusted size of US$ 401.9 million by 2028 with a CAGR of 5.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Restriction Endonucleases market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Restriction Endonucleases landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The Restriction Endonuclease industry is relatively concentrated, and the players mainly come from North America and Western Europe. In the world wide, major manufactures mainly are New England Biolabs, Thermo Fisher Scientific, Takara Bio, Illumina, Agilent Technologies, Roche, GE Healthcare, Promega Corporation, Qiagen and Jena Biosciences, etc, with about 88% market shares.
This report focuses on Restriction Endonucleases volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Restriction Endonucleases market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Restriction Endonucleases Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Type I
Type II
Type III
Type IV
Others
Segment by Application
Academic & Research Institutes
Hospitals & Diagnostic Centers
Biopharmaceutical
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent
Roche
GE Healthcare
Promega
Qiagen
Jena Biosciences

Frequently Asked Questions